Picture of Sedana Medical AB (publ) logo

SEDANA Sedana Medical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Brief: Sedana Medical Says Received Positive Outcome For European Registration Application For Drug Sedaconda

July 20 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL RECEIVES APPROVAL FOR EUROPEAN DOSSIER
    * RECEIVED A POSITIVE OUTCOME FOR ITS EUROPEAN REGISTRATION
APPLICATION FOR DRUG SEDACONDA FOR INHALED SEDATION
    * FROM OCTOBER 1(ST), ANACONDA WILL CHANGE NAME TO SEDACONDA
ACD
    * NOW WORKING TO GET NATIONAL MARKET APPROVALS AS SOON AS
POSSIBLE
IN COUNTRIES WHERE DCP APPROVAL APPLIES
    * PLANS TO SUBMIT APPLICATIONS FOR ADDITIONAL EU COUNTRIES
IN
COMING SIX MONTHS.

Source text for Eikon:  ID:nWkr9mWlkQ 
Further company coverage:  SEDANA.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sedana Medical AB (publ)

See all news